Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Luana Mota Martins, Carla Solange de Melo Escorcio Dourado, Larysse Maira Campos-Verdes, Fabiane Araújo Sampaio, Camila Maria Simplício Revoredo, Danylo Rafhael Costa-Silva, Maria da Conceição Barros-Oliveira, Elmo de Jesus Nery Junior, Lucia Maria do Rego-Medeiros, Luiz Henrique Gebrim, Francisco Adelton Alves-Ribeiro, Gilmara Péres Rodrigues, Diego Cipriano Chagas, Dilina do Nascimento Marreiro, Benedito Borges da Silva
Published Dec 3, 2019 · Vol. 10, No. 64 · pp. 6879-6884
Keywords: breast neoplasms, fibroadenoma, matrix metalloproteinase-2, matrix metalloproteinase-9, immunohistochemistry
Simone Pacini, Marina Montali, Francesco Mazziotta, Claudia P. Schifone, Lucia Macchia, Vittoria Carnicelli, Francesca M. Panvini, Serena Barachini, Laura Notarfranchi, Giovanni Battista Previti, Gabriele Buda, Mario Petrini
Published Nov 26, 2019 · Vol. 10, No. 63 · pp. 6781-6790
Published Nov 26, 2019 · Vol. 10, No. 63 · pp. 6805-6815
Keywords: non-small cell lung cancer (NSCLC), UL16-binding protein (ULBP), prognostic factor, MICA/B (MHC class I chain-related molecule A and B), NK cell